Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Centre de Référence des Maladies Rares du Calcium et du Phosphore, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Pediatr Transplant. 2020 Nov;24(7):e13809. doi: 10.1111/petr.13809. Epub 2020 Aug 26.
In children, vitamin D deficiency is common after renal transplantation. Besides promoting bone and muscle development, vitamin D has immunomodulatory effects, which could protect kidney allografts. The purpose of this study was to assess the association between vitamin D status and the occurrence of renal rejection.
We studied a retrospective cohort of 123 children, who were transplanted at a single institution between September 2008 and April 2019. Patients did not receive vitamin D supplementation systematically. In addition, factors influencing vitamin D status were analyzed using univariate and multivariate analyses.
Median 25-hydroxy-vitamin D (25-OH-D) concentration was close to reference values at the time of transplantation (30 ng/mL (min-max 5-100)), but rapidly decreased within the first 3 months to 19 ng/mL (min-max 3-91) (P < .001). The overall acute rejection rate was 7%. The clinical rejection rate (5% vs 9%), subclinical rejection (12% vs 36%), and borderline changes (21% vs 28%) were not statistically different during the follow-up between the 3-month 25-OH-D < 20 ng/mL and 3-month 25-OH-D > 20 ng/mL groups. There was a correlation between the 25-OH-D levels and PTH concentration at 3 months (r = -.2491, P = .01), but no correlation between the 3-month 25-OH-D and the season of the year (F = 0.19, P = .90; F = 1.34, P = .27, respectively). Multivariate analyses revealed that age and mGFR at 3 months, were independent predictors of mGFR at 12 months.
Our data show that vitamin D deficiency can develop rapidly after transplantation; vitamin D levels at 3 months are not associated with lower mGFR or a higher rejection rate at 1 year in children as opposed to adult recipients.
在儿童中,肾移植后维生素 D 缺乏很常见。除了促进骨骼和肌肉发育外,维生素 D 还具有免疫调节作用,可以保护肾移植。本研究旨在评估维生素 D 状态与肾排斥反应发生的关系。
我们研究了 2008 年 9 月至 2019 年 4 月在一家机构接受移植的 123 名儿童的回顾性队列。患者没有系统地接受维生素 D 补充。此外,还使用单变量和多变量分析来分析影响维生素 D 状态的因素。
中位数 25-羟维生素 D(25-OH-D)浓度在移植时接近参考值(30ng/mL(最小值-最大值 5-100)),但在最初的 3 个月内迅速下降至 19ng/mL(最小值-最大值 3-91)(P<.001)。总急性排斥率为 7%。在随访期间,3 个月 25-OH-D<20ng/mL 组与 3 个月 25-OH-D>20ng/mL 组之间,临床排斥率(5%比 9%)、亚临床排斥率(12%比 36%)和边缘改变率(21%比 28%)没有统计学差异。25-OH-D 水平与 3 个月时 PTH 浓度之间存在相关性(r=-.2491,P=.01),但 3 个月时 25-OH-D 与当年季节之间没有相关性(F=0.19,P=.90;F=1.34,P=.27)。多变量分析显示,3 个月时的年龄和 mGFR 是 12 个月时 mGFR 的独立预测因素。
我们的数据表明,维生素 D 缺乏在移植后会迅速发展;与成年受者相比,儿童在 3 个月时的维生素 D 水平与 1 年后较低的 mGFR 或较高的排斥率无关。